Nipocalimab demonstrates positive data in pregnant patients at risk for hemolytic disease of fetus, newborn
The rare condition can lead to life-threatening anemia in the fetus and currently lacks FDA-approved treatments.
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Vaginal metabolites may be early predictors of spontaneous preterm birth
In a recent study, an association was found between vaginal metabolites and spontaneous preterm birth.
S1E3: Dr. Emily S. Miller: Placental pathology and MVM evidence
This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Emily S. Miller, with Northwestern Medicine in Chicago.
Active postnatal care associated with periviable infant survival rate
In a recent study, the infant survival rate among periviable infants varied based on the type of active postnatal care received at certain gestational ages.
FDA advisory panel votes to withdraw approval of premature birth prevention drug
An advisory panel for the US Food and Drug Administration voted 14-1 to withdraw 17α-hydroxyprogesterone caproate (Makena; Covis Pharma) from the market.
2 Clarke Drive Cranbury, NJ 08512